CHICAGO -- Classifying inflammatory subphenotypes of acute respiratory distress syndrome (ARDS) with bedside lab testing was ...

Aerogen, the global leader in high-performance aerosol drug delivery,, in collaboration with Enterprise Ireland, the Irish ...

Selection Follows Positive Phase 3 Results for Paridiprubart Demonstrating Statistically Significant Mortality Reductions in ...

Compremium recently won FDA Breakthrough Device designation for its noninvasive Quantis CVP (central venous pressure) measurement device.

The convergence of clinical and biomarker effects in a biomarker enriched subgroup in the Phase II ALS dataset with AP-101 is ...

Trial of ultrasound-based, catheter-directed thrombolysis is one of several anticipated st ...

Back from the brink after huge population decline, there is still much homeowners can do to encourage these beautiful birds ...

Imagine being asked to sit alone in a quiet room for 15 minutes with nothing to do—no phone, no music, no external ...

When it comes to bladder cancer, it’s important to note the differences between muscle-invasive and non-muscle-invasive bladder cancer, as it can affect the staging of the cancer. The “stage” (spread) ...

Fezolinetant (also called Veoza and made by Astellas Pharma) is recommended to treat moderate to severe symptoms in final draft NICE guidance. Hot flushes and night sweats can hugely affect daily life ...

The expanded care model is intended to help individuals experiencing conditions such as back pain, neck strain, joint injuries, and accident-related trauma. SALEM, OR, UNITED STATES, March 18, 2026 ...